We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+9.96%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$51.2B
AUM Growth
+$4.14B
Cap. Flow
+$445M
Cap. Flow %
0.87%
Top 10 Hldgs %
19.89%
Holding
3,234
New
648
Increased
710
Reduced
838
Closed
835

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.99B
2
MSFT icon
Microsoft
MSFT
+$522M
3
AMD icon
Advanced Micro Devices
AMD
+$511M
4
AMZN icon
Amazon
AMZN
+$318M
5
AAPL icon
Apple
AAPL
+$317M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$402M
2
MCD icon
McDonald's
MCD
+$375M
3
V icon
Visa
V
+$366M
4
META icon
Meta Platforms (Facebook)
META
+$319M
5
ADBE icon
Adobe
ADBE
+$272M

Sector Composition

Rank Sector Weight
1 Technology 19.58%
2 Healthcare 17.11%
3 Consumer Discretionary 13.31%
4 Financials 8%
5 Industrials 6.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROCL
3051
DELISTED
Roth CH Acquisition V Co. Common Stock
ROCL
-53,910
Closed -$556K
THCP
3052
DELISTED
Thunder Bridge Capital Partners IV, Inc. Class A Common Stock
THCP
-961,111
Closed -$9.73M
MRO
3053
DELISTED
Marathon Oil Corporation
MRO
-42,531
Closed -$1.02M
DPCS
3054
DELISTED
DP Cap Acquisition Corp I Class A Ordinary Shares
DPCS
-151,920
Closed -$1.59M
NVEI
3055
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
-144,608
Closed -$6.29M
FNVT
3056
DELISTED
Finnovate Acquisition Corp. Class A Ordinary Shares
FNVT
-285,049
Closed -$2.97M
INTE
3057
DELISTED
Integral Acquisition Corporation 1 Class A Common Stock
INTE
-448,247
Closed -$4.6M
NPAB
3058
DELISTED
New Providence Acquisition Corp. II Class A Common Stock
NPAB
-791,491
Closed -$8.21M
CCTS
3059
DELISTED
Cactus Acquisition Corp. 1 Limited Class A Ordinary Share
CCTS
-128,934
Closed -$1.35M
AEAE
3060
DELISTED
AltEnergy Acquisition Corp
AEAE
-666,985
Closed -$6.92M
GRTS
3061
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
-422,045
Closed -$1.17M
EGRX
3062
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
-65,967
Closed -$1.87M
XFIN
3063
DELISTED
ExcelFin Acquisition Corp Class A Common Stock
XFIN
-905,893
Closed -$9.41M
ASCB
3064
DELISTED
A SPAC II Acquisition Corp. Ordinary Shares
ASCB
-234,115
Closed -$2.43M
HA
3065
DELISTED
Hawaiian Holdings, Inc.
HA
-574,815
Closed -$5.27M
TUP
3066
DELISTED
Tupperware Brands Corporation
TUP
-533,388
Closed -$1.33M
TCOA
3067
DELISTED
Zalatoris Acquisition Corp.
TCOA
-742,500
Closed -$7.6M
LLAP.WS
3068
CALL
DELISTED
Terran Orbital Corporation Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
LLAP.WS
-100,000
Closed -$184K
CVII
3069
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
-5,046,108
Closed -$51.2M
KCGI
3070
DELISTED
Kensington Capital Acquisition Corp. V
KCGI
-182,979
Closed -$1.91M
TWOU
3071
DELISTED
2U Inc
TWOU
-22,913
Closed -$4.71M
CONN
3072
DELISTED
Conn's Inc.
CONN
-104,356
Closed -$632K
SBOW
3073
DELISTED
SilverBow Resources, Inc.
SBOW
-38,775
Closed -$886K
CATC
3074
DELISTED
CAMBRIDGE BANCORP
CATC
-12,352
Closed -$801K
OSG
3075
DELISTED
Overseas Shipholding Group Inc.
OSG
-196,363
Closed -$766K

Similar funds

Marshall Wace's Q2 2023 Portfolio in Review

As of Q2 2023, Marshall Wace held 3,234 positions worth $51.2B, up 8.8% from $47.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace's Q2 2023 filing shows 648 new, 710 increased, 838 reduced and 835 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B. The largest sale was Gilead Sciences, an estimated $402M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Marshall Wace's largest Q2 2023 buy was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.
  • Marshall Wace added most to Microsoft in Q2 2023, an estimated $522M increase.
  • Marshall Wace's biggest Q2 2023 reduction was Gilead Sciences, cutting an estimated $402M.
  • Marshall Wace fully exited Cloudflare in Q2 2023, selling an estimated $136M.
  • Marshall Wace's ten largest holdings make up 20% of its $51.2B portfolio in Q2 2023.
  • Marshall Wace opened 648 new positions and closed 835 in Q2 2023.
  • Marshall Wace's portfolio value rose 8.8% quarter-over-quarter to $51.2B.

Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.